Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Terminated 2Completed 2Withdrawn 1Unknown 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 33Neoplasms 16Prostatic Neoplasms 15Lung Neoplasms 11Carcinoma, Hepatocellular 11Multiple Myeloma 9Colorectal Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Papillomavirus Infections 6Pain, Postoperative 6Neoplasm Metastasis 6Liver Neoplasms 6Leukemia, Myeloid, Acute 6Stomach Neoplasms 5Recurrence 5Lymphoma, Non-Hodgkin 4Kidney Neoplasms 4Heart Failure 4Glioma 4Febrile Neutropenia 4Carcinoma, Renal Cell 4Brain Neoplasms 4Warts 3Vomiting 3Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Skin Neoplasms 3Rectal Neoplasms 3Pituitary Neoplasms 3

Interventions

remimazolam 1Propofol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Recruiting × Delirium × Clear all
NCT04532606 2025-07-30

Impact of Remimazolam on Prognosis After Bladder Cancer Surgery

Peking University First Hospital

Phase 4 Recruiting
1,128 enrolled
Genitourinary

Emergence Delirium, Urinary Bladder Neoplasms, Delirium

Data powered by HemOnc (CC BY 4.0) Colophon âš¡